December 06, 2020
Oncopeptides presents new data from phase 2 ANCHOR combination study in multiple myeloma at American Society of Hematology meeting ASH
Media
December 02, 2020
Targovax ASA: Invitation to online presentation at 10:00 CET 2 December
December 01, 2020
Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin[®] in Diffuse Large B Cell Lymphoma
December 01, 2020
Targovax announces impressive objective responses as well as effects on non-injected lesions in ONCOS-102 trial in anti-PD1 refractory melanoma patients
November 30, 2020
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
November 30, 2020
Strong CERAMENT data published in Science Advances
November 30, 2020
Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
November 30, 2020
Nordic Nanovector announces change of its Oslo Børs ticker symbol to “NANOV”
November 24, 2020
Strongbridge Biopharma plc Announces Publication of Secondary Endpoints Data from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome in the Journal, Pituitary
November 24, 2020
Targovax demonstrates encouraging survival data for ONCOS-102 in mesothelioma